Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

04 Jul 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

07 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

01 Jul 2015 GlobalData 62 $125.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

30 Jun 2015 Wright Reports 55 $75.00

Will Sun Pharmaceutical Industries Limited Perform Long Term?

04 Jun 2015 Sadif Analytics Prime 11 $25.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

03 Jun 2015 GlobalData 58 $125.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - May 30, 2015

Sun Pharma (Bloomberg: SUNP IN, HOLD, TP – Rs 1,025, 6% upside from CMP of Rs 966) SUNP Q4 PAT declined 44% YoY due to Ran...

01 Jun 2015 Axis Capital Limited 6 $58.00

Sun Pharma - Q4FY15 Result Update - "HOLD" - KRChoksey Research

“Disappointing quarter” Result highlights Sun Pharma posted Q4FY15 & FY15 consolidated results after integration with Ranbaxy...

01 Jun 2015 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $69.00

Sun Pharmaceutical Industries Limited | Q4FY15 Result Update | Increased operating cost impact earnings; however, outlook remain positive; maintain HOLD rating with revised PT of Rs918 (from Rs921 earlier)

Sun Pharmaceutical Industries Limited | Q4FY15 Result Update Increased operating cost impact earnings; however, outlook rema...

31 May 2015 IndiaNivesh Securities Pvt Ltd 6 $58.00

SUN.NS - Event Transcript of Sun Pharmaceutical Industries Ltd conference call, May 29, 2015 / 9:00AM ET

Edited Event Transcript of SUN.NS conference call, May 29, 2015 / 9:00AM ET Boston, Jun 2, 2015 (Thomson StreetEvents) ...

29 May 2015 Thomson Reuters StreetEvents 24 $75.00